APA (7th ed.) Citation

JL, C. M., LA, G. T., A, G., & OG, C. (2024). Rituximab as a First-line Treatment for Autoimmune Hemolytic Anemia in Multicentric Castleman's Disease. Cureus, 16(4), e59080. https://doi.org/10.7759/cureus.59080

Chicago Style (17th ed.) Citation

JL, Cáceres Medina, González Torres LA, Gamboa-Meza A, and Cantu-Rodriguez OG. "Rituximab as a First-line Treatment for Autoimmune Hemolytic Anemia in Multicentric Castleman's Disease." Cureus 16, no. 4 (2024): e59080. https://doi.org/10.7759/cureus.59080.

MLA (9th ed.) Citation

JL, Cáceres Medina, et al. "Rituximab as a First-line Treatment for Autoimmune Hemolytic Anemia in Multicentric Castleman's Disease." Cureus, vol. 16, no. 4, 2024, p. e59080, https://doi.org/10.7759/cureus.59080.